These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15324639)

  • 1. [Cost-effectiveness of varicella vaccination in Spanish adolescents].
    Peña-Rey I; Pérez-Farinós N; Cortés-García M; Amela-Heras C
    Gac Sanit; 2004; 18(4):287-94. PubMed ID: 15324639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
    Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
    Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
    Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
    Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of varicella vaccination in Canada.
    Brisson M; Edmunds WJ
    Vaccine; 2002 Jan; 20(7-8):1113-25. PubMed ID: 11803072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Gamboa-Garay O; Castañeda-Orjuela C; Velandia-González M; Alvis-Guzmán N
    Vaccine; 2013 Jan; 31(2):402-9. PubMed ID: 23174195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of varicella vaccination programs: an update of the literature.
    Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
    Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella vaccination in England and Wales: cost-utility analysis.
    Brisson M; Edmunds WJ
    Arch Dis Child; 2003 Oct; 88(10):862-9. PubMed ID: 14500303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of varicella vaccine programs for Australia.
    Scuffham PA; Lowin AV; Burgess MA
    Vaccine; 1999 Oct; 18(5-6):407-15. PubMed ID: 10519929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of routine childhood varicella vaccination in Germany.
    Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
    Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost benefit analysis of routine varicella vaccination in Spain.
    Díez Domingo J; Ridao M; Latour J; Ballester A; Morant A
    Vaccine; 1999 Mar; 17(11-12):1306-11. PubMed ID: 10195765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives.
    Hsu HC; Lin RS; Tung TH; Chen TH
    Vaccine; 2003 Sep; 21(25-26):3982-7. PubMed ID: 12922134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
    Smith KJ; Roberts MS
    Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of chickenpox in reproductive-age women: cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles.
    Smith WJ; Jackson LA; Watts DH; Koepsell TD
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):535-45. PubMed ID: 9764625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
    Tseng HF; Tan HF; Chang CK
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.
    Hanslik T; Boëlle PY; Schwarzinger M; Carrat F; Freedberg KA; Valleron AJ; Flahault A
    Vaccine; 2003 Sep; 21(25-26):3614-22. PubMed ID: 12922090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
    EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.